Amgen Inc.

Historical 13F Holders

Symbol
AMGN
CUSIP
031162100
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 20 116 k $29.2 M
2025 Q4 3,168 391 M $128 B
2025 Q3 2,942 427 M $120 B
2025 Q2 2,972 438 M $122 B
2025 Q1 3,045 423 M $132 B
2024 Q4 2,984 419 M $109 B
2024 Q3 2,948 419 M $135 B
2024 Q2 2,917 429 M $134 B
2024 Q1 2,837 444 M $126 B
2023 Q4 2,846 434 M $125 B
2023 Q3 2,612 406 M $117 B
2023 Q2 2,489 406 M $90.2 B
2023 Q1 2,533 410 M $98.9 B
2022 Q4 2,600 441 M $118 B
2022 Q3 2,410 411 M $93.2 B
2022 Q2 2,437 414 M $101 B
2022 Q1 2,423 425 M $103 B
2021 Q4 2,367 427 M $96.6 B
2021 Q3 2,204 424 M $90.8 B
2021 Q2 2,278 434 M $106 B
2021 Q1 2,295 440 M $110 B
2020 Q4 2,305 444 M $103 B
2020 Q3 2,212 447 M $114 B
2020 Q2 2,175 454 M $107 B
2020 Q1 2,124 456 M $92.4 B
2019 Q4 2,208 468 M $113 B
2019 Q3 1,980 465 M $90.1 B
2019 Q2 1,963 470 M $86.6 B
2019 Q1 1,985 481 M $91.2 B
2018 Q4 1,979 510 M $99.1 B
2018 Q3 1,887 518 M $107 B
2018 Q2 1,853 550 M $101 B
2018 Q1 1,833 533 M $90.8 B
2017 Q4 1,818 577 M $100 B
2017 Q3 1,694 577 M $108 B
2017 Q2 1,690 578 M $99.6 B
2017 Q1 1,706 597 M $98.1 B
2016 Q4 1,632 591 M $86.6 B
2016 Q3 1,608 596 M $99.4 B
2016 Q2 1,550 604 M $92.3 B
2016 Q1 1,507 630 M $90.4 B
2015 Q4 1,553 616 M $101 B
2015 Q3 1,446 618 M $85.5 B
2015 Q2 1,436 610 M $93.6 B
2015 Q1 1,409 617 M $98.7 B
2014 Q4 1,416 624 M $99.4 B
2014 Q3 1,301 616 M $86.6 B
2014 Q2 1,254 624 M $73.7 B
2014 Q1 1,254 614 M $75.8 B